Abstract Dyslipidemia is a major risk factor for cardio-cerebrovascular disease. Although the prevalence among Korean adults is very high, its management is known to be poor. The aim of this study was to access the prevalence, awareness, treatment, and control rates of dyslipidemia according to treatment guideline rather than diagnostic criteria. The risk factors for cardio-cerebrovascular disease were evaluated to apply the appropriate risk-based threshold of the lipid treatment targets according to risk category. Analysis was done using nationally representative data (n = 16,263) collected from adults aged 20 years and older participating the Korea National Health and Nutrition Examination Survey (KNHANS) 2010-2012. The age-standardized prevalence rate of dyslipidemia according to treatment criteria was 34.1%. Of these prevalent cases, however, only 19.2% were aware; 9.5% treated; and 8.7% controlled. The age-standardized control rate among treated persons was 47.5%. Men had a significantly higher prevalence than women (39.7% vs. 28.8%), but a significantly lower rate of awareness, treatment, and control (16.0% vs. 22.3%, 7.7% vs. 11.3%, and 6.1% vs. 11.2%, respectively). As the higher risk category, the prevalence rate was higher but the control rate was lower. The prevalence of patients with diabetes was 82.5% when applying the treatment criteria (LDL-cholesterol level of ≥ 100 mg/dL and triglyceride level of ≥ 200 mg/dL). However, only 11.9 % of these were controlled, whose LDL-cholesterol and triglycerides were lower than the treatment goals. Our findings suggest that effective strategies are required to decrease the gap between the prevalence of dyslipidemia and the following treatment. It would be worthwhile to strengthen the follow-up management of patients with dyslipidemia in the National Health Screening Program, especially in the high risk group of cardio-cerebrovascular disease.
Note: LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol. 1) Dyslipidemia was defined by the presence of one or more of the followings: ① hyper-LDL-cholesterolemia (LDL-C ≥ 160 mg/dL), ② hypertriglyceridemia (TG ≥ 200 mg/dL), ③ hypo-HDL-cholesterolemia (HDL-C < 40 mg/dL), ④ previous diagnosis by a medical doctor, or ⑤ current use of lipid-lowering medications. 2) A person with dyslipidemia was considered "aware" if he/she had a previous diagnosis of dyslipidemia by a doctor. Those who reported taking prescribed medicine more than 20 days per month to lower their blood cholesterol were considered "treated." A person with dyslipidemia were considered "controlled" if his/her LDL-C, TG, and HDL-C did not meet the diagnostic criteria (LDL-C < 160 mg/dL, TG < 200 mg/dL, and HDL-C ≥ 40 mg/dL). A treated person was classified as "controlled among treated" if his/her LDL-C, TG, and HDL-C did not meet the diagnostic criteria. 11.2%, 5.9% vs. 11.4%, 그리고 37.2% vs. 54.6%). 1) Dyslipidemia according to treatment criteria was defined by the presence of one or more of the followings: ① hyper-LDL-cholesterolemia according to treatment criteria, ② hypertriglyceridemia according to treatment criteria, ③ previous diagnosis by a medical doctor, or ④ current use of lipid-lowering medications. 2) A person with dyslipidemia was considered "aware" if he/she had a previous diagnosis of dyslipidemia by a doctor. Those who reported taking prescribed medicine more than 20 days per month to lower their blood cholesterol were considered "treated." A person with dyslipidemia were considered "controlled" if his/her LDL-C and TG reached the treatment goal according to his/her risk category. A treated person was classified as "controlled among treated" if his/her LDL-C and TG reached the treatment goal. (Fig 2의 B 참조) . 남성의 고중성지방혈증 유병률은 20대부터 40대까지 진단기준이 치료기준보다 유의적으로 높았지만, 50대 이후에는 유의적인 차이가 존재하지 않았다 (Fig 2의 C 참조) . 여성의 유병률은 50
심뇌혈관질환 위험군 범주별 분포

대까지 진단기준이 치료기준보다 유의적으로 높았고, 60
대 이후에는 거의 같은 수준이었다 (Fig 2의 D 참조) 
